Coenzyme Q10:A Review of Its Promise as a Neuroprotectant
Authors:
- A. Joyce YoungAYA. Joyce Young
- Stephanie JohnsonSJStephanie Johnson
- David C. SteffensDSDavid C. Steffens
- P. Murali DoraiswamyPDP. Murali Doraiswamy
- 1 January 2007
- journal article
- review article
- Published by Cambridge University Press (CUP) in CNS Spectrums
- Vol. 12 (1) , 62-68
Abstract
Coenzyme Q10 (CoQ10) is a powerful antioxidant that buffers the potential adverse consequences of free radicals produced during oxidative phosphorylation in the inner mitochondrial membrane. Oxidative stress, resulting in glutathione loss and oxidative DNA and protein damage, has been implicated in many neurodegenerative disorders, including Alzheimer's disease, Parkinson's disease, and Huntington's disease. Experimental studies in animal models suggest that CoQ10 may protect against neuronal damage that is produced by ischemia, atherosclerosis and toxic injury. Though most have tended to be pilot studies, there are published preliminary clinical trials showing that CoQ10 may offer promise in many brain disorders. For example, a 16-month randomized, placebo-controlled pilot trial in 80 subjects with mild Parkinson's disease found significant benefits for oral CoQ10 1,200 mg/day to slow functional deterioration. However, to date, there are no published clinical trials of CoQ10 in Alzheimer's disease. Available data suggests that oral CoQ10 seems to be relatively safe and tolerated across the range of 300–2,400 mg/day. Randomized controlled trials are warranted to confirm CoQ10's safety and promise as a clinically effective neuroprotectant.Keywords
This publication has 31 references indexed in Scilit:
- Pilot trial of high dosages of coenzyme Q10 in patients with Parkinson's diseaseExperimental Neurology, 2004
- Targeting energy metabolism in Huntington's diseaseThe Lancet, 2004
- The Natural Treatment of HypertensionThe Journal of Clinical Hypertension, 2004
- Vitamins, Supplements, Herbal Medicines, and ArrhythmiasCardiology in Review, 2004
- Idebenone for treatment of Friedreich’s ataxia?Neurology, 2003
- Can coenzyme Q10 improve vascular function and blood pressure? Potential for effective therapeutic reduction in vascular oxidative stressBioFactors, 2003
- Friedreich's Ataxia: Disease mechanisms, antioxidant and Coenzyme Q10therapyBioFactors, 2003
- Mitochondrial Dysfunction in Friedreich's Ataxia: From Pathogenesis to Treatment PerspectivesFree Radical Research, 2002
- Heart Hypertrophy and Function Are Improved by Idebenone in Friedreich's AtaxiaFree Radical Research, 2002
- Assessment of coenzyme q10 tolerability in huntington's diseaseMovement Disorders, 1996